Volume 8 Issue 4, Apr 2023

ISSN: 2095-9907 

EISSN: 2059-23635 

2023 impact factor 40.8 

 (Clarivate Analytics, 2024)
Volume 8 Issue 4, Apr 2023:
Letter
Pyrotinib plus capecitabine could significantly improve overall survival in HER2-positive metastatic breast cancer
Xiuwen Guan,Fei Ma  ORCID: orcid.org/0000-0001-9432-1902,Qiao Li,Shanshan Chen,Ying Fan,Jiayu Wang,Yang Luo,Pin Zhang,Qing Li &…Binghe Xu